|
Q4 2020
Filed on Feb 11, 2021
|
40
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
125
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
9,048
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
124
|
N/A
|
|
Adamis Pharmaceuticals Corp
|
Q4 2020
Filed on Feb 11, 2021
|
863
|
N/A
|
|
Adaptimmune Therapeutics PLC
|
Q4 2020
Filed on Feb 11, 2021
|
224
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
44
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
161
|
N/A
|
|
Advanced Disp Svcs Inc Del
|
Q4 2020
Filed on Feb 11, 2021
|
121
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
438
|
$13.97 - $14.87
$6.12K - $6.51K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
375
|
$25.04 - $27.41
$9.39K - $10.3K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
120
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
275
|
$5.57 - $6.88
$1.53K - $1.89K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
410
|
$8.73 - $10.51
$3.58K - $4.31K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
1,750
|
$10.21 - $12.42
$17.9K - $21.7K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
773
|
$12.4 - $15.25
$9.59K - $11.8K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
1,500
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
1,150
|
$10.2 - $12.2
$11.7K - $14K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
329
|
$10.8 - $11.63
$3.55K - $3.83K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
250
|
$11.38 - $12.53
$2.85K - $3.13K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
1,500
|
$13.42 - $14.77
$20.1K - $22.2K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
425
|
$10.61 - $13.11
$4.51K - $5.57K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
200
|
$17.79 - $25.99
$3.56K - $5.2K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
127
|
$3.5 - $5.35
$445 - $679
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
40
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
300
|
$7.16 - $9.55
$2.15K - $2.87K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
800
|
$19.74 - $22.43
$15.8K - $17.9K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
188
|
$47.77 - $50.77
$8.98K - $9.54K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
1,750
|
$5.75 - $7.13
$10.1K - $12.5K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
100
|
$4.53 - $7.8
$453 - $780
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
1,450
|
$9.7 - $12.04
$14.1K - $17.5K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
487
|
$4.55 - $4.66
$2.22K - $2.27K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
525
|
$3.72 - $3.83
$1.95K - $2.01K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
350
|
$10.75 - $12.04
$3.76K - $4.21K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
1,555
|
$12.72 - $15.2
$19.8K - $23.6K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
400
|
$21.63 - $24.61
$8.65K - $9.84K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
1,007
|
$10.07 - $11.45
$10.1K - $11.5K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
2,463
|
$13.09 - $14.71
$32.2K - $36.2K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
4,450
|
$7.57 - $8.07
$33.7K - $35.9K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
2,206
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
130
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
34
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
250
|
$30.86 - $34.21
$7.72K - $8.55K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
139
|
$14.3 - $23.1
$1.99K - $3.21K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
300
|
$6.45 - $10.92
$1.94K - $3.28K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
52
|
$33.66 - $44.33
$1.75K - $2.31K
|
|
Voya Nat Res Equity Income F
|
Q4 2020
Filed on Feb 11, 2021
|
825
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
3,086
|
$4.09 - $4.98
$12.6K - $15.4K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
650
|
$12.0 - $13.98
$7.8K - $9.09K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
500
|
$9.61 - $10.73
$4.81K - $5.37K
|
|